Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have dramatically revolutionized lung cancer treatment, providing unprecedented clinical benefits. However, immune-related pneumonitis (IRP) caused by ICIs has aroused widespread concern due to its high rate of discontinuation and mortality. This netwo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xinru, Zhang, Zhonghan, Hou, Xue, Zhang, Yaxiong, Zhou, Ting, Liu, Jiaqing, Lin, Zhihuan, Fang, Wenfeng, Yang, Yunpeng, Ma, Yuxiang, Huang, Yan, Zhao, Hongyun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462235/
https://www.ncbi.nlm.nih.gov/pubmed/32863271
http://dx.doi.org/10.1136/jitc-2020-001170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462235/
https://www.ncbi.nlm.nih.gov/pubmed/32863271
http://dx.doi.org/10.1136/jitc-2020-001170

Ejemplares similares